Sorafenib (SKI-606)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sorafenib (SKI-606), covering 2009-10-27 to 2009-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating SKI-606 in Subject With Solid Tumors [Phase 1]